The results demonstrated that regrowth of tumor vessels is certain after IFN-α therapy is discontinued; further, tumor growth is not inhibited when IFN-α treatment is re-initiated and re-initiated treatment is associated with increased platelet-derived growth factor (PDGF)-A expression. The gene discussed is PDGFA; the disease is neoplasm.